Evaluation of PSMA-PET and mpMRI in High-risk Prostate Cancer - Using Histopathologic Validation

NCT06565247 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

60

Enrollment

OTHER_GOV

Sponsor class

Conditions

Prostate Cancer

Interventions

DRUG: [18F]PSMA-PET
DEVICE: MRI sequences optimized for prostate cancer examinations

Sponsor

Region Västerbotten

Collaborators

[object Object]
[object Object]
[object Object]